IGF-II regulates PTEN expression in the mammary gland

Roger A. Moorehead, Carlo V. Hojilla, Ian De Belle, Geoffrey A. Wood, Jimmie E. Fata, Eileen D. Adamson, Katrina L. Watson, Dylan R. Edwards, Rama Khokha

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)

Abstract

The tumor suppressor PTEN is altered in many cancers, including breast cancer, but only a handful of factors are known to control its expression. PTEN plays a vital role in cell survival and proliferation by regulating Akt phosphorylation, a key component of the phosphatidylinositol 3 kinase (PI3K) pathway. Here we show that insulin-like growth factor-II (IGF-II), which signals through PI3K, regulates PTEN expression in the mammary gland. IGF-II injection into mouse mammary gland significantly increased PTEN expression. Transgenic IGF-II expression also increased mammary PTEN protein, leading to reductions in Akt phosphorylation, epithelial proliferation, and mammary morphogenesis. IGF-II induced PTEN promoter activity and protein levels and this involved the immediate early gene egr-1. Thus, we have identified a novel negative feedback loop within the PI3K pathway where IGF-II induces PTEN expression to modulate its physiologic effects.
Original languageEnglish
Pages (from-to)50422-50427
Number of pages6
JournalJournal of Biological Chemistry
Volume278
Issue number50
DOIs
Publication statusPublished - 12 Dec 2003

Cite this